Asthma and allergy: A worldwide problem of meanings and management?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 8, 2002, Pages 663-672

  Crane, J ^a   Wickens, K ^a   Beasley, R ^a   Fitzharris, P ^a  

^a Wellington Asthma Research Group   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FENOTEROL; HISTAMINE; IMMUNOGLOBULIN E; METHACHOLINE; PLACEBO; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

AIRWAY; ALLERGIC DISEASE; ALLERGY; ASTHMA; BRONCHITIS; DISEASE SEVERITY; HAY FEVER; HEALTH CARE PERSONNEL; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PEAK EXPIRATORY FLOW; PREVALENCE; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; RISK FACTOR; SIDE EFFECT; TH1 CELL; TH2 CELL; WHEEZING;

AGE DISTRIBUTION; ASTHMA; DATA COLLECTION; DERMATITIS; ECZEMA; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; PREVALENCE; RHINITIS; SYNDROME; WORLD HEALTH;

EID: 0036338061     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.25004.x     Document Type: Review

References (78)

1. Hay fever, a post industrial revolution epidemic: A history of its growth during the 19th century
2. Asthma, allergy and atopy in three south east Asian populations
3. International comparison of asthma prevalence in children: Australia, Switzerland and Chile
4. Childhood asthma in four countries: A comparative survey
5. Worldwide variations in the prevalence of asthma symptoms. The International Study of Asthma and Allergies in Childhood (ISAAC)
6. Variations in the prevalence of respiratory symptoms, self reported asthma attacks and use of asthma medication in the European Community Respiratory Health Survey (ECRHS)
7. Morbidity statistics from general practice
8. Prevalence and natural history of asthma in schoolchildren
9. Prevalence of asthma in Michigan
10. A national study of asthma in childhood
11. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study
12. Underdiagnosis and under treatment of asthma in childhood
13. Wheezy bronchitis revisited
14. Asthma and wheezing in the first years of life
15. Prevalence of bronchial hyperresponsiveness in children: The relationship between asthma and skin reactivity to allergens in two communities
16. Changing prevalence of asthma in Australian children
17. Different nebulisers may explain Australian findings
18. Prevalence of asthma in Melbourne schoolchildren: Changes over 26 years
19. A survey of childhood asthma in Aberdeen
20. Respiratory symptoms and atopy in Aberdeen schoolchildren: Evidence from two surveys 25 years apart
21. Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren
22. Trends in prevalence and severity of childhood asthma
23. Changes in asthma prevalence: Two surveys 15 years apart
24. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
25. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991
26. Investigations into the increase in hay fever and eczema at age 16 between the 1958 and 1970 British birth cohorts
27. Hypertonic saline challenge in an epidemiologic survey of asthma in children
28. The UK Working Party's diagnostic criteria for atopic dermatitis I. Derivation of a minimum set of discriminatory for atopi dermatitis
29. Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults
30. Development of seasonal allergic rhinitis during the first 7 years of life
31. Ethnic differences in prevalence of asthma symptoms and bronchial hyperresponsiveness in New Zealand schoolchildren
32. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children. The International Study of Asthma and Allergies in Childhood (ISAAC)
33. Incidence of allergic rhinitis in general practice
34. Changing prevalence of allergic rhinitis and asthma
35. Epidemiologic evidence for asthma and rhinitis comorbidity
36. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood
37. Is atopy increasing?
38. Longitudinal changes in allergen skin test reactivity in a community population sample
39. Increasing prevalence of specific IgE to aeroallergens in an adult population: Two cross-sectional surveys 8 years apart: The Copenhagen Allergy Study
40. Serum IgE levels in white and Metis communities in Saskatchewan
41. Asthma and IgE levels in rural and urban communities of the Gambia
42. Hay fever, hygiene, and household size
43. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus
44. Cell mediated immunity after measles in Guinea-Bissau: Historical cohort study
45. The inverse association between tuberculin responses and atopic disorder
46. Prevalence of hepatitis A antibodies in Italy
47. Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease
48. Role of microbial burden in aetiology of allergy and asthma
49. Evidence for the increase in asthma worldwide
50. Secular trends in the occurrence of asthma among children and young adults: Critical appraisal of repeated cross sectional surveys
51. Global Initiative for asthma management and prevention
52. Family size infection and atopy: The first decade of the 'hygiene hypothesis'
53. Regular versus symptomatic aerosol bronchodilator treatment of asthma
54. Asthma mortality in New Zealand: A two year national study
55. Prescribed fenoterol and death from asthma in New Zealand: Case control study
56. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81
57. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: A further case-control study
58. The use of beta-agonists and the risk of death and near death from asthma
59. End of the New Zealand asthma mortality epidemic
60. The decline in hospital admissions for asthma in New Zealand
61. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: What lessons have been learned?
62. Regular inhaled beta-agonist treatment in bronchial asthma
63. Asthma control during long term treatment with regular inhaled salbutamol and salmeterol
64. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma
65. Regular albuterol, nedocromil sodium and bronchial inflammation in asthma
66. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects
67. Regular vs as-needed inhaled salbutamol in asthma control
68. Comparison of regularly sheduled with as-needed use of albuterol in mild asthma
69. Regular inhaled salbutamol and asthma control: The TRUST randomised trial
70. A placebo controlled clinical trial of regular monotherapy with short acting and long acting B2 agonists in allergic asthmatic patients
71. United States audit of asthma therapy
72. Epidemiology and pathogenesis of asthma
73. European audit of asthma therapy
74. International trends in hospital admission rates for asthma
75. Increase in hospital admissions for childhood asthma: Trends in referral, severity, and readmissions from 1970 to 1985 in a health region of the United Kingdom